Showcasing major breakthroughs in cancer care from worldwide clinical trials, Project Oncology® educates and assists the healthcare professionals who dedicate their lives to helping patients fight cancer.
Here you’ll find leading oncologists discuss and share essential cancer care strategies for all different types of cancer. And as worldwide clinical trials continue to explore new screening tests and discover novel treatment options, you can rest assured that you’ll always catch the latest in cancer research with Project Oncology®.
Thrombosis-Free Survival Data that May Inform the Way We Manage Patients with Polycythemia Vera
Thrombosis-Free Survival Data that May Inform the Way We Manage Patients with Polycythemia Vera
An Introduction to Squamous Cell Carcinoma of the Head and Neck
An Introduction to Squamous Cell Carcinoma of the Head and Neck
Bridging the Disparity Gap in Multiple Myeloma Care: Navigating Challenges, Seizing Opportunities
Bridging the Disparity Gap in Multiple Myeloma Care: Navigating Challenges, Seizing Opportunities
EMERALD Trial: An Analysis of Key Biomarkers and Patient Subgroups
EMERALD Trial: An Analysis of Key Biomarkers and Patient Subgroups
Exploring Early Usage of a 2L ITP Treatment Option: Clinical Profile and Access Resources
Exploring Early Usage of a 2L ITP Treatment Option: Clinical Profile and Access Resources
Advanced Endometrial Carcinoma: A Look Into Care Considerations
Advanced Endometrial Carcinoma: A Look Into Care Considerations
Cholangiocarcinoma: Treatment with Targeted Therapies
Cholangiocarcinoma: Treatment with Targeted Therapies
Advancements in Pretreated HR+/HER2- Metastatic Breast Cancer
Advancements in Pretreated HR+/HER2- Metastatic Breast Cancer
Advancements in Pretreated Metastatic Triple-Negative Breast Cancer
Advancements in Pretreated Metastatic Triple-Negative Breast Cancer
Advances in HR-MDS: Updates in Diagnosis, Risk Assessment, and Current Standard of Care Challenges
Advances in HR-MDS: Updates in Diagnosis, Risk Assessment, and Current Standard of Care Challenges
Navigating Treatment Goals With a CDK4/6 Inhibitor in HR+/HER2- mBC
Navigating Treatment Goals With a CDK4/6 Inhibitor in HR+/HER2- mBC
Updates in CLL Treatment: 5-Year Off Treatment Analyses of the CLL14 and MURANO Trials
Updates in CLL Treatment: 5-Year Off Treatment Analyses of the CLL14 and MURANO Trials
Advances in BPDCN Treatment: Targeting Its Pathophysiology
Advances in BPDCN Treatment: Targeting Its Pathophysiology
Managing BPDCN as a Targeted Treatment Option
Managing BPDCN as a Targeted Treatment Option
An Approach to Treating BPDCN Patients with Prior or Concomitant Hematologic Malignancies
An Approach to Treating BPDCN Patients with Prior or Concomitant Hematologic Malignancies